Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
Lancet (London, England)|December 10, 2022
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trialKhaelqu Zaman, Ananda S Bandyopadhyay, Masuma Hoque, et al.
Nature Microbiology|November 27, 2025
Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spreadDarlan da Silva Candido, Simon Dellicour, Laura V Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health|September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in SwedenElizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 1, 2008
Active manipulation of the spatial energy distribution of laser-accelerated proton beamsD C Carroll, P McKenna, O Lundh, et al.
Physical Review Letters|February 7, 2007
Magnetic reconnection and plasma dynamics in two-beam laser-solid interactionsP M Nilson, L Willingale, M C Kaluza, et al.
The Journal of Infectious Diseases|December 23, 2016
The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled TrialJacob John, Sidhartha Giri, Arun S Karthikeyan, et al.
The Lancet. Microbe|May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trialsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2017
The Immunogenicity of Fractional Intradermal Doses of the Inactivated Poliovirus Vaccine Is Associated With the Size of the Intradermal Fluid BlebJack Bibby, Yauba Saidu, Ama Umesi, et al.
Lancet (London, England)|December 14, 2020
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trialsXavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, et al.
Pageof 35